An observational study in Myopia and Anisometropia, sponsored by Buddhist Tzu Chi General Hospital. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 8 Years to 23 Years. Per ClinicalTrials.gov, last updated 2024-12-20.
Sponsored by Buddhist Tzu Chi General Hospital · Observational
Among 39 studies in Myopia with a site in Taiwan — 6 open to participants now, 8 under way, none of them phase 3. Myopia · Taiwan.
Among the 39 studies in Myopia with a site in Taiwan, this one is one of 3 that started in 2025, is one of 9 observational ones, and was the 36th registered.
1,159 studies on the registry are indexed under Myopia; 225 are open to participants now.
This study's planned enrollment of 50 is below the median of 150 across 204 observational studies indexed under Myopia.
Browse Myopia studies →6 of the 39 studies in Myopia with a site in Taiwan are open now, in 1 country. Each count lists the studies.
Of the 122 Myopia studies recruiting now, 19 (16%) set no upper age limit and 102 (84%) stop at 75 or younger; 86 take children under 18; 53 take healthy volunteers.
This study: 8 Years to 23 Years · all sexes.
The full table on the hub →39 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 3 started in 2025.
Median enrollment 69 across the 30 interventional studies, 100 across the 9 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
15 of 39 have an industry lead sponsor. The 10 most frequent:
Buddhist Tzu Chi General Hospital is the lead sponsor of 88 studies on the registry; 20 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Buddhist Tzu Chi General Hospital has 3 studies filed under Myopia — fewer than ten, so there is no comparison to draw.
3 of the studies in Myopia with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06579287Sunhawk Vision Biotech, Inc.A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control | 2026-12 |
| NCT07345416Menicon Co., Ltd.A Clinical Trial Assessing the Efficacy and Safety of ST-1 Silicone Hydrogel Daily Disposable Soft Contact Lenses Compared to Miru 1day UpSide | 2026-12-31 |
| NCT07107646National Taiwan University HospitalExploring Perceptual Learning in Blurred Gabor Discrimination for Low-Myopic Children | 2027-06-30 |
Among the 39 studies in Myopia with a site in Taiwan, from their registry updates:
The effectiveness of Misight 1 Day Contact Lens in retarding anisometropic progression has not been investigated before. This study is aimed to elucidate the efficacy of Misight 1 Day Contact Lens for anisometropia control.
We enroll the clinical patients who was diagnosed with anisometropia (meaning that myopia exceeds 100 degree diopters during the refraction examination, and the difference between the other eye is more than 100 degree diopters). Age limit was 8 to 23 years old. The purpose and process were carefully addressed to the subjects and their guardians who signed an informed consent form before commencing this study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Myopic children use Misight 1 Day Contact Lens every day for myopia and anisometropia control.
Device: Misight 1 Day Contact Lens
Misight 1 Day Contact Lens wearing for myopia control
Changes of the visual acuity in myopic children with different Misight 1 Day Contact Lens
The investigators measure the visual acuity of myopic children with different Misight 1 Day Contact Lens.
Time frame: From the date of starting treatment, the visual acuity was measured 1 week, 1month and every 3 months up to 24 months.
Changes of axial length in myopic children with different Misight 1 Day Contact Lens
The investigators measure the axial length(mm) of eyeball of myopic children with different diopter of Misight 1 Day Contact Lens.
Time frame: From the date of starting treatment, the axial length was measured, then repeat measure were performed every 6 months up to 24 months
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Jan 2025; primary completion for Dec 2025, 11 months later.
Of 87 non-industry observational studies under Myopia, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 90. This study's planned 11 months is below that.
Counting every sponsor, half of 96 studies reached it within 24 months; a quarter within 10 and three quarters within 59.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Buddhist Tzu Chi General Hospital